"Just one word-- Nucleotides" is the opening slide in the "State of the Gilead" talk by the company's founder and CEO Michael L. Riordan in July 1992, shortly after Gilead's IPO. Nucleotides have proven to be an important advance against viral infections, including HIV/AIDS, hepatitis B, and hepatitis C. Excerpts from the presentation:
"Gilead's business is science."
"We are only as good as our principles,"
"We're in this boat together."
"We learn from each other."
"We are receptive to the ideas of others."
"Diverse personalities are accepted."